## **Core Concept**
Waldenström's macroglobulinemia is a type of non-Hodgkin lymphoma characterized by the proliferation of lymphoplasmacytic cells in the bone marrow, leading to the overproduction of a monoclonal IgM antibody. This condition is a type of lymphoproliferative disorder. The key aspect of this disease is the presence of IgM paraprotein.

## **Why the Correct Answer is Right**
The correct answer, , is associated with Waldenström's macroglobulinemia because this condition is indeed linked to a specific mutation in the MYD88 gene, which is a gain-of-function mutation (MYD88 L265P). This mutation leads to the activation of NF-κB, promoting cell survival and proliferation. Waldenström's macroglobulinemia is also characterized by the presence of IgM monoclonal gammopathy.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while certain genetic mutations and chromosomal abnormalities are associated with Waldenström's macroglobulinemia, the specific and most directly related condition or genetic alteration is not listed here.
- **Option B:** This option is incorrect as there isn't a well-established direct link to make it the best choice for Waldenström's macroglobulinemia.
- **Option C:** This option is incorrect because it does not accurately represent the condition associated with Waldenström's macroglobulinemia.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that Waldenström's macroglobulinemia often presents with symptoms related to the hyperviscosity syndrome due to high levels of IgM, such as visual disturbances, headaches, and fatigue. The presence of the MYD88 L265P mutation is found in a significant majority of patients, making it a valuable diagnostic clue.

## **Correct Answer:** .